Literature DB >> 17141477

Social cognition in schizophrenia: relationships with neurocognition and negative symptoms.

Mark J Sergi1, Yuri Rassovsky, Clifford Widmark, Christopher Reist, Stephen Erhart, David L Braff, Stephen R Marder, Michael F Green.   

Abstract

Despite the growing importance of social cognition in schizophrenia, fundamental issues concerning the nature of social cognition in schizophrenia remain unanswered. One issue concerns the strength of the relationships between social cognition and key features of the disorder such as neurocognitive deficits and negative symptoms. The current study employed structural equation modeling to examine three key questions regarding the nature of social cognition in schizophrenia: 1) Are social cognition and neurocognition in schizophrenia better modeled as one or two separate constructs? 2) Are social cognition and negative symptoms in schizophrenia better modeled as one or two separate constructs?, and 3) When social cognition, neurocognition, and negative symptoms are included in a single model, is social cognition more closely related to neurocognition or to negative symptoms? In this cross sectional study, one hundred outpatients with schizophrenia or schizoaffective disorder were administered measures of social cognition, neurocognition, and negative symptoms. A two-factor model that represented social cognition and neurocognition as separate constructs fit the data significantly better than a one-factor model, suggesting that social cognition and neurocognition are distinct, yet highly related, constructs. Likewise, a two-factor model that represented social cognition and negative symptoms as separate constructs fit the data significantly better than a one-factor model, suggesting that social cognition and negative symptoms are distinct constructs. A three-factor model revealed that the relationship between social cognition and neurocognition was stronger than the relationship between social cognition and negative symptoms. The current findings start to provide insights into the structure of social cognition, neurocognition, and negative symptoms in schizophrenia.

Entities:  

Mesh:

Year:  2006        PMID: 17141477     DOI: 10.1016/j.schres.2006.09.028

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  102 in total

1.  Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness.

Authors:  Piotr J Quee; Lisette van der Meer; Richard Bruggeman; Lieuwe de Haan; Lydia Krabbendam; Wiepke Cahn; Niels C L Mulder; Durk Wiersma; André Aleman
Journal:  Schizophr Bull       Date:  2010-11-22       Impact factor: 9.306

2.  Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults.

Authors:  Hsien-Yuan Lane; Yi-Ching Liu; Chieh-Liang Huang; Ching-Liang Hsieh; Yi-Lin Chang; Lauren Chang; Yue-Cune Chang; Wen-Ho Chang
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

3.  Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia.

Authors:  Morris Bell; Hector W H Tsang; Tamasine C Greig; Gary J Bryson
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

4.  Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Authors:  Dwight Dickinson; James M Gold
Journal:  Schizophr Bull       Date:  2007-08-16       Impact factor: 9.306

5.  Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity.

Authors:  Charles M Olbert; David L Penn; Robert S Kern; Junghee Lee; William P Horan; Steven P Reise; Kevin N Ochsner; Stephen R Marder; Michael F Green
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

6.  Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.

Authors:  Michael F Green; Junghee Lee; Kevin N Ochsner
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

Review 7.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

Review 8.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

9.  Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

Authors:  A McCleery; M F Green; G S Hellemann; L E Baade; J M Gold; R S E Keefe; R S Kern; R I Mesholam-Gately; L J Seidman; K L Subotnik; J Ventura; K H Nuechterlein
Journal:  Psychol Med       Date:  2015-04-28       Impact factor: 7.723

10.  Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia.

Authors:  Ivy F Tso; Tyler B Grove; Stephan F Taylor
Journal:  Schizophr Res       Date:  2010-01-03       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.